|Articles|July 24, 2015

Cogstate Releases Online Cognitive Screening Solution for Alzheimer's Trial

Author(s)Applied Clinical Trials Editorial Staff

This new version release optimizes patient recruitment with study-specific prescreening workflows and a delivery platform that allows for self-administered cognitive assessments on any modality including tablet-based assessments

Cogstate, a cognitive science and medical technology company, announced the latest version of its remote cognitive assessment solution for pre-screening participants in clinical trials, Precision Recruitment™ 2.1.

This new version release optimizes patient recruitment with study-specific prescreening workflows and a delivery platform that allows for self-administered cognitive assessments on any modality including tablet-based assessments. Other important new features include:

Functionality allowing pre-screened participants to select an investigator site in their area, with automatic site notification for a more seamless enrolment process.

The ability to deploy the solution in many different languages, as required for global clinical trials

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Cogstate Releases Online Cognitive Screening Solution for Alzheimer's Trial

Newsletter

Related Articles